Certara, Inc.(CERT)
Application Software
Vertical SaaS (Industry-Specific)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | Feehery William F CHIEF EXECUTIVE OFFICER | Purchase | +24,096.384 | +1.03%2,360,769.384 | $8.30 | $200,000 | View SEC filing | |
| 2025-09-11 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale | -51,224 | -40.91%73,979 | $10.92 | $559,366 | View SEC filing | |
| 2024-10-08 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale | -5,409 | -9.75%50,091 | $11.03 | $59,661 | View SEC filing | |
| 2024-09-10 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale | -51,224 | -33.94%99,704 | $11.29 | $578,319 | View SEC filing | |
| 2024-04-04 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale | -14,427 | -22.36%50,091 | $16.85 | $243,161 | View SEC filing | |
| 2024-04-03 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -3,000 | -1.70%173,524 | $18.00 | $54,000 | View SEC filing | |
| 2024-03-05 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -3,000 | -1.81%162,368 | $18.28 | $54,840 | View SEC filing | |
| 2024-02-21 | SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS | Sale | -5,000 | -8.34%54,975 | $18.00 | $90,000 | View SEC filing | |
| 2024-02-14 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -6,000 | -3.50%165,368 | $18.00 | $108,000 | View SEC filing | |
| 2023-12-27 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -6,000 | -3.38%171,368 | $18.00 | $108,000 | View SEC filing | |
| 2023-09-12 | Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF | Sale | -51,224 | -28.44%128,883 | $14.60 | $747,870 | View SEC filing | |
| 2023-08-23 | BROSHY ERAN Director | Purchase | +5,000 | +53.42%14,360 | $15.81 | $79,058 | View SEC filing | |
| 2023-06-06 | SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV | Sale | -19,104 | -24.16%59,975 | $21.55 | $411,691 | View SEC filing | |
| 2023-05-15 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -5,000 | -2.74%177,368 | $20.82 | $104,100 | View SEC filing | |
| 2023-04-17 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -5,000 | -2.67%182,368 | $23.66 | $118,300 | View SEC filing | |
| 2023-03-07 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -10,000 | -5.14%184,564 | $21.45 | $214,500 | View SEC filing | |
| 2023-02-03 | Traynor Richard M. SVP AND GENERAL COUNSEL | Sale | -15,000 | -7.16%194,564 | $20.00 | $300,000 | View SEC filing | |
| 2022-12-12 | EQT Avatar Parent L.P. 10% Owner | Sale | -29,954,521 | -100.00%0 | $15.00 | $449,317,815 | View SEC filing | |
| 2022-11-23 | Pedersen Leif E PRESIDENT, SOFTWARE | Sale | -51,223 | -22.59%175,500 | $15.55 | $796,518 | View SEC filing | |
| 2022-11-16 | SLAINE MASON P Director | Sale | -250,000 | -27.46%660,322 | $15.56 | $3,891,238 | View SEC filing | |
| 2022-11-15 | WALSH MATTHEW M Director | Sale | -12,059 | -6.70%167,901 | $14.74 | $177,750 | View SEC filing | |
| 2022-11-14 | SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV | Sale | -2,387 | -3.09%74,859 | $13.48 | $32,177 | View SEC filing | |
| 2022-08-23 | McLean Stephen M. Director | Purchase | +20,000 | +90.91%42,000 | $16.32 | $326,400 | View SEC filing | |
| 2022-08-18 | Schemick Michael Andrew CHIEF FINANCIAL OFFICER | Purchase | +25,000 | +5.07%517,870 | $16.64 | $416,000 | View SEC filing | |
| 2022-08-18 | SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV | Sale | -10,000 | -11.30%78,490 | $17.71 | $177,100 | View SEC filing |
1-25 of 108